POLISCOPE
Back to bills
Part ofHealth →

The civic record

Read. Follow. Verify.
High Impact

Iowa Senate Bill 2155 classifies specific abortion-inducing drugs as Schedule III controlled substances and…

Original title: A bill for an act relating to schedule III controlled substances, and making penalties applicable.

Last action · February 4, 2026: Subcommittee: Schultz, Blake, and Bousselot. S.J. 199 .Sponsor: Doug Campbell

Introduced
Committee
Floor Vote
Passed
Law

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

Public stanceCommunity reactions are separate from the official record and reporting.

What This Bill Would Do

Senate File 2155 classifies misoprostol, mifepristone, and methotrexate as under Iowa law. The measure makes the unauthorized manufacture, distribution, or dispensing of these substances a punishable by fines ranging from $1,000 to $50,000.

Why it matters

The measure alters the legal classification of three pharmaceutical compounds, subjecting unauthorized handlers to felony prosecution and specific statutory fines that do not apply under standard drug regulations.

Who It Would Affect

Groups the bill's text would affect if enacted, as described in the record. Being affected is not a position for or against it.

Directly affected

Manufacturers, distributors, and dispensers

Individuals or entities handling misoprostol, mifepristone, or methotrexate face felony charges and mandatory fine ranges for unauthorized activities.

Key Facts

  • Misoprostol is added to Schedule III controlled substances under Iowa Code section 124.208.
  • Mifepristone is added to Schedule III controlled substances under Iowa Code section 124.208.
  • Methotrexate is added to Schedule III controlled substances under Iowa Code section 124.208.
  • Manufacturing, distributing, or dispensing a Schedule III controlled substance under this provision constitutes a class "C" felony.
Show all 5 facts
  • Violators are subject to a mandatory fine of not less than $1,000 nor more than $50,000 in addition to standard penalties under Code section 902.9.

Frequently Asked Questions

What substances are reclassified under this bill?
The bill adds misoprostol, mifepristone, and methotrexate to .
What are the legal consequences for unauthorized distribution of these substances?
A person who manufactures, distributes, or dispenses these substances commits a and faces a fine between $1,000 and $50,000.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Where This Stands

Currently in committee. The next step in the legislative lifecycle is Floor Vote.

Procedural history

2 actions
  1. Feb 4, 2026Senate
    Subcommittee: Schultz, Blake, and Bousselot. S.J. 199 .
  2. Jan 29, 2026SenateIntroduced
    Introduced, referred to Judiciary. S.J. 168 .

Version history

Only one version on file - nothing to compare yet. As later stages (committee substitute, engrossed, enrolled) are captured, the redline appears here.

View official text →

Lobbying Activity

No state lobbying filings in our records match this bill. Federal lobbying reports (LDA) cover Congress, so they are not listed on state bills.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Sponsors

Connected Entities

Doug Campbell, General Assembly of the State of Iowa
PersonDoug Campbell“Primary sponsor of Senate File 2155”Map →
OrganizationGeneral Assembly of the State of Iowa“Legislative body enacting the bill”Map →

Sources

Open source document

www.legis.iowa.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy90
    Intensity of disagreement among stakeholders
  • Entertainment10
    Compellingness for a non-policy-wonk reader
  • Buzz65
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record